A generic minimization random allocation and blinding system on web

Journal of Biomedical Informatics

Volumn 39, Issue 6, 2006, Pages 706-719

  Cai, Hongwei ^a   Xia, Jielai ^a   Xu, Dezhong ^a   Gao, Donghuai ^a   Yan, Yongping ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Blinding; Minimization; Multi treatment groups; Random allocation; WWW

Indexed keywords

COMPUTER PROGRAMMING LANGUAGES; COMPUTER SIMULATION; DATABASE SYSTEMS; OPTIMIZATION; PATIENT TREATMENT; RANDOM PROCESSES; STATISTICAL METHODS;

BLINDING SYSTEM; GENERIC MINIMIZATION; MULTI TREATMENT GROUPS; RANDOM ALLOCATION;

WORLD WIDE WEB;

ARTICLE; CLINICAL STUDY; COMPUTER PROGRAM; DATA BASE; INTERNET; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; RANDOMIZATION; SIMULATION;

CLINICAL TRIALS; HUMANS; INTERNET; MODELS, STATISTICAL; MULTICENTER STUDIES; PROGRAMMING LANGUAGES; RANDOM ALLOCATION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SAMPLING STUDIES; SINGLE-BLIND METHOD; SOFTWARE; SOFTWARE DESIGN;

EID: 33750695321     PISSN: 15320464     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbi.2006.02.015     Document Type: Article

References (23)

1. Schulz K.F., and Grimes D.A. Generation of allocation sequences in randomised trials: chance, not choice. Lancet 359 (2002) 515-519 Review
2. Schulz K.F., and Grimes D.A. Blinding in randomised trials: hiding who got what. Lancet 359 (2002) 696-700
3. Lachin J.M. Properties of simple randomization in clinical trials. Control Clin Trials 9 (1988) 312-326
4. Altman D.G., Schulz K.F., Moher D., et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134 (2001) 663-694 Review
5. Kernan W.N., Viscoli C.M., Makuch R.W., Brass L.M., and Horwitz R.I. Stratified randomization for clinical trials. J Clin Epidemiol 52 (1999) 19-26 Review
6. Taves D.R. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther 15 (1974) 443-453
7. Pocock S.J., and Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31 (1975) 103-115
8. Scott N.W., McPherson G.C., Ramsay C.R., and Campbell M.K. The method of minimization for allocation to clinical trials. a review. Control Clin Trials 23 (2002) 662-674 Review
9. McEntegart D.J. The pursuit of balance using stratified and dynamic randomization techniques: an overview. Drug Inf J 37 (2003) 293-308
10. Halpern J., and Brown Jr. B.W. Sequential treatment allocation procedures in clinical trials-with particular attention to the analysis of results for the biased coin design. Stat Med 5 (1986) 211-229
11. Lachin J.M., Matts J.P., and Wei L.J. Randomization in clinical trials: conclusions and recommendations. Control Clin Trials 9 (1988) 365-374
12. Hagino A., Hamada C., Yoshimura I., Ohashi Y., Sakamoto J., and Nakazato H. Statistical comparison of random allocation methods in cancer clinical trials. Control Clin Trials 25 (2004) 572-584
13. Blair E. Gold is not always good enough: the shortcomings of randomization when evaluating interventions in small heterogeneous samples. J Clin Epidemiol 57 (2004) 1219-1222
14. Treasure T., and MacRae K.D. Minimisation: the platinum standard for trials? Randomisation doesn't guarantee similarity of groups; minimisation does. Br Med J 317 (1998) 362-363
15. ; 2005 [accessed].
16. Kenjo Y., Antoku Y., Akazawa K., Hanada E., Kinukawa N., and Nose Y. An easily customized, random allocation system using the minimization method for multi-institutional clinical trials. Comput Methods Programs Biomed 62 1 (2000) 45-49
17. Cai H.W., Xia J.L., Xu D.Z., Gao D.H., and Zhang Y. A random allocation system using minimization method on Internet. J Fourth Mil Med Univ 25 (2004) 1278-1280 In Chinese
18. Brandt C.A., Morse R., Matthews K., Sun K., Deshpande A.M., Gadagkar R., et al. Metadata-driven creation of data marts from an EAV-modeled clinical research database. Int J Med Inform 65 (2002) 225-241
19. ; 2005 [accessed].
20. Lewis J.A. Statistical principles for clinical trials (ICH E9): an introductory note on an international guideline. Stat Med 18 (1999) 1903-1942
21. Reed J.V., and Wickham E.A. Practical experience of minimization in clinical trials. Pharmaceut Med 3 (1988) 349-359
22. Negm R.S., Verma M., and Srivastava S. The promise of biomarkers in cancer screening and detection. Trends Mol Med 8 (2002) 288-293 Review
23. Baumgartner C, Matyas G, Steinmann B, Eberle M, Stein JI, Baumgartner D. A bioinformatics framework for genotype-phenotype correlation in humans with Marfan syndrome caused by FBN1 gene mutations. J Biomed Inform 2005 Jul 29; [Epub ahead of print].